CEACAM5 and cancer: The detection of 94% patients with cancer across stages and subtypes, including 91% of stage I/II and 96% of stage III/IV, was achieved with 80% specificity by combining fragmentation features, clinical risk factors, and CEA levels followed by CT imaging.